Division of Traumatology, Surgical Critical Care, and Emergency Surgery, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Division of Interventional Radiology, Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
JAMA Surg. 2015 Jul;150(7):650-6. doi: 10.1001/jamasurg.2015.97.
Optimizing the nature and sequence of diagnostic imaging when managing lower gastrointestinal hemorrhage may reduce subsequent morbidity and mortality.
To determine if preceding visceral arteriography with computed tomographic angiography (CTA) in acute lower gastrointestinal hemorrhage increases hemorrhage identification and localization and to determine if CTA was superior to nuclear scintigraphy when used as a pre-angiogram test.
DESIGN, SETTING, AND PARTICIPANTS: Analysis was conducted of prospectively acquired data from an interventional radiology database and of individual electronic medical records from an academic tertiary medical center. On January 1, 2009, a new, evidence-based, institutional protocol that formally incorporated CTA to manage acute lower gastrointestinal hemorrhage was launched after multidisciplinary consultation. All records of patients who underwent visceral angiography (VA) for acute lower gastrointestinal hemorrhage from January 1, 2005, to December 31, 2012, were evaluated.
Imaging, procedural, and operative details were abstracted from the medical records of all patients who underwent VA for lower gastrointestinal hemorrhage.
Visceral angiography results and efficacy were compared in patients before and after protocol implementation and compared based on which imaging method was used prior to angiography.
A total of 161 angiographic procedures were performed during the study period (78 before and 83 after protocol implementation). Use of CTA increased from 3.8% to 56.6%, and use of nuclear scintigraphy decreased from 83.3% to 50.6% following protocol implementation (P < .001). Preceding angiography with CTA resulted in similar angiography contrast administration (mean [SD] amount for CTA prior to VA, 135 [63] vs 160 [77] mL; P = .18) and fluoroscopy time (mean [SD], 26.3 [16.8] vs 32.2 [34.9] minutes; P = .34). Although nuclear scintigraphy and CTA had similar sensitivity and specificity, localization of hemorrhage site by CTA was more precise and consistent with angiography findings. As a pre-angiography test, compared with nuclear scintigraphy, CTA reduced overall the number of imaging studies required (mean [SD] number per patient admission, 2.1 [0.3] vs 2.5 [0.8]; P = .005) and resulted in administration of more overall contrast (mean [SD], 220 [80] vs 130 [70] mL; P < .001) without worsening renal function.
Preceding VA with a diagnostic study improves positive localization of the site of lower gastrointestinal hemorrhage compared with VA alone. Increasing the use of CTA for pre-angiography imaging may reduce overall imaging studies while appearing to increase positive yield at VA. Computed tomographic angiography can be used as part of a lower intestinal hemorrhage management algorithm and does not appear to worsen renal function despite the additional contrast load.
优化管理下消化道出血时的诊断成像的性质和顺序可能会降低后续的发病率和死亡率。
确定急性下消化道出血时先行 CT 血管造影(CTA)是否会增加出血的识别和定位,并确定 CTA 是否优于核闪烁照相术作为血管造影前的测试。
设计、地点和参与者:对介入放射学数据库中前瞻性采集的数据以及学术三级医疗中心的个体电子病历进行了分析。2009 年 1 月 1 日,在多学科咨询后,推出了一项新的、基于证据的机构方案,正式纳入 CTA 以管理急性下消化道出血。评估了 2005 年 1 月 1 日至 2012 年 12 月 31 日期间因急性下消化道出血而行内脏血管造影(VA)的所有患者的记录。
从所有因下消化道出血而行 VA 的患者的病历中提取了影像学、程序和手术细节。
比较了方案实施前后 VA 结果和疗效,并根据血管造影前使用的影像学方法进行了比较。
在研究期间共进行了 161 次血管造影术(方案实施前 78 次,实施后 83 次)。CTA 的使用率从 3.8%增加到 56.6%,核闪烁照相术的使用率从 83.3%下降到 50.6%(P < .001)。在血管造影前行 CTA 检查,造影剂的使用量相似(血管造影前 CTA 的平均[SD]量为 135[63]ml 与 160[77]ml;P = .18),透视时间相似(平均[SD],26.3[16.8]与 32.2[34.9]分钟;P = .34)。虽然核闪烁照相术和 CTA 的敏感性和特异性相似,但 CTA 对出血部位的定位更准确,与血管造影结果一致。作为血管造影前的检查,与核闪烁照相术相比,CTA 减少了整体所需的影像学检查数量(每位患者入院的平均[SD]数量,2.1[0.3]与 2.5[0.8];P = .005),并且使用了更多的造影剂(平均[SD],220[80]与 130[70]ml;P < .001),而肾功能恶化。
与单独进行 VA 相比,在 VA 前进行诊断性检查可提高下消化道出血部位的阳性定位率。增加 CTA 在血管造影前成像中的应用可能会减少整体影像学检查,同时似乎会增加 VA 的阳性产量。CTA 可用于下消化道出血管理算法的一部分,尽管造影剂负荷增加,但似乎不会导致肾功能恶化。